Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $274.01 | 4 | 86.4% |
| Education | $43.06 | 2 | 13.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $241.03 | 2 | $0 (2021) |
| Allergan Inc. | $31.50 | 1 | $0 (2019) |
| Novo Nordisk Inc | $19.23 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $13.75 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $11.56 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.23 | 1 | Novo Nordisk Inc ($19.23) |
| 2023 | $13.75 | 1 | GlaxoSmithKline, LLC. ($13.75) |
| 2021 | $119.11 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($119.11) |
| 2020 | $11.56 | 1 | AstraZeneca Pharmaceuticals LP ($11.56) |
| 2019 | $31.50 | 1 | Allergan Inc. ($31.50) |
| 2018 | $121.92 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($121.92) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Diabetes | ||||||
| 04/26/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: VACCINES | ||||||
| 10/28/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.11 | General |
| Category: DIABETES | ||||||
| 10/28/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 02/20/2019 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $31.50 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $121.92 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 664 | 1,007 | $92,242 | $43,126 |
| 2022 | 15 | 655 | 960 | $82,341 | $42,012 |
| 2021 | 14 | 750 | 1,043 | $104,438 | $41,561 |
| 2020 | 18 | 787 | 1,119 | $85,354 | $28,550 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 234 | $45,220 | $19,719 | 43.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 83 | 83 | $20,667 | $10,168 | 49.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 65 | $9,009 | $3,826 | 42.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 31 | $8,024 | $3,728 | 46.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 77 | 158 | $1,328 | $1,153 | 86.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 66 | 103 | $1,854 | $1,057 | 57.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 42 | 49 | $1,127 | $806.54 | 71.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 46 | 55 | $1,210 | $721.60 | 59.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 63 | 96 | $960.00 | $709.98 | 74.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 34 | 45 | $724.00 | $428.40 | 59.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 26 | 28 | $896.00 | $271.34 | 30.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 11 | 11 | $275.00 | $208.12 | 75.7% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 13 | 14 | $726.00 | $164.91 | 22.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 12 | 13 | $156.00 | $114.92 | 73.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 22 | $66.00 | $48.40 | 73.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 213 | $38,766 | $18,420 | 47.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 60 | 60 | $14,940 | $7,637 | 51.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 33 | $8,085 | $4,290 | 53.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 70 | $8,820 | $4,256 | 48.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 29 | 29 | $2,465 | $2,037 | 82.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 63 | 91 | $1,638 | $940.30 | 57.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 31 | 31 | $1,364 | $834.90 | 61.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 41 | 49 | $1,127 | $810.79 | 71.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 63 | 90 | $900.00 | $669.04 | 74.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 43 | 48 | $1,056 | $634.28 | 60.1% |
About Dr. Thomas Bilisko, MD
Dr. Thomas Bilisko, MD is a Internal Medicine healthcare provider based in Wyoming, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275537011.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Bilisko, MD has received a total of $317.07 in payments from pharmaceutical and medical device companies, with $19.23 received in 2024. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($274.01).
As a Medicare-enrolled provider, Bilisko has provided services to 2,856 Medicare beneficiaries, totaling 4,129 services with total Medicare billing of $155,249. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Wyoming, MI
- Active Since 06/09/2005
- Last Updated 06/21/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1275537011
Products in Payments
- JARDIANCE (Drug) $119.11
- VRAYLAR (Drug) $31.50
- Rybelsus (Drug) $19.23
- SHINGRIX (Biological) $13.75
- BREZTRI AEROSPHERE (Drug) $11.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wyoming
Mounir Ghali, M.d, M.D
Internal Medicine — Payments: $363,968
Dr. Michael Sumners, D.o, D.O
Internal Medicine — Payments: $9,438
Dr. Gunjan Gholkar, M.d, M.D
Internal Medicine — Payments: $7,082
David Tabor, Do, DO
Internal Medicine — Payments: $6,045
Dr. Soheil Assar, Do, DO
Internal Medicine — Payments: $2,492
Dr. Lucas Watts, D.o, D.O
Internal Medicine — Payments: $1,807